STAMBP and melanoma: For the identification of Wnt antagonist peptides (A, B, C, D), we investigated the physical interactions of CREB/β-catenin in B16F1 melanoma cells treated with α-MSH or Wnt agonist peptides using a PLA (see Figure 1B).